Leonel Martinez, MD
Otolaryngology · Lawrence, KSNPI 1598915217
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Intersect ENT, Inc. at 45.4% of the total.
Across 65 payments — averaging $82.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$2K
- Aerin Medical Inc.$2K
- Medtronic$225
- Stryker$224
- GSK$158
- Smith+Nephew$104
- plus $546 from 12 others
What the payments were for
- Consulting fees$1002%
- Travel & lodging$2,61549%
- Food & beverage$2,66350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 13 | $2,444 |
| Aerin Medical Inc. | 19 | $1,678 |
| Medtronic | 2 | $225 |
| Stryker | 5 | $224 |
| GSK | 5 | $158 |
| Smith+Nephew | 3 | $104 |
| Regeneron Healthcare Solutions, Inc. | 4 | $97 |
| Alk-abello, Inc | 1 | $96 |
| AstraZeneca | 1 | $84 |
| Sanofi | 2 | $69 |
| Optinose US, Inc. | 3 | $61 |
| Titan Surgical Group, LLC | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Integra Lifesciences Corporation | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Covidien LP | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$2,376
- SINUVA$2,131
- VIVAER STYLUS$1,297
- ENTELLUS - XPRESS ENT DILATION SYSTEM$144
- RHINAER STYLUS$119
How this compares
$5,378 in reported general payments places this provider in the 80th percentile of 87 otolaryngology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 89 | $2,492 |
| Levocetirizine Dihydrochloride | 75 | $1,247 |
| Ipratropium Bromide | 41 | $1,239 |
| Fluticasone Propionate | 72 | $1,024 |
| Montelukast Sodium | 93 | $682 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $466 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 45 | $458 |
| Mometasone Furoate | 11 | $326 |
| Mupirocin | 29 | $288 |
| Prednisone | 36 | $234 |
| Ciprofloxacin Hcl | 23 | $230 |
| Methylprednisolone | 32 | $225 |
| Levothyroxine Sodium | 26 | $87 |
| Omeprazole | 22 | $86 |
| Hydroxyzine Hcl | 13 | $57 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Lawrence
- Lee ReussnerLawrence$811
- Hinrich StaeckerKansas City$499K
- Stanley McClurgMerriam$133K
- Douglas CowanLeawood$32K
- Jennifer VillwockKansas City$26K
- David RudmanOverland Park$18K
- Nicholas WirtzMerriam$14K
- Meha FoxKansas City$12K
- Kiran KakaralaKansas City$10K
- Christopher RoseLeawood$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.